Common use of Adverse Event Reporting Clause in Contracts

Adverse Event Reporting. Both Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both All Parties acknowledge the obligation to comply with the Protocol Clinical Investigation Plan and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical TrialInvestigation. Both All Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both Parties acknowledge the obligation to comply with the Protocol Clinical Investigation Plan and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical TrialInvestigation. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both All Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both All Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both All Parties acknowledge the obligation to comply with the Protocol and / or and/or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both All Parties agree to fulfil and ensure that their Personnel, employees and/or Agents fulfil regulatory requirements with respect to the reporting of adverse events. 3.6.1 [DELETE IF NOT APPLICABLE]

Adverse Event Reporting. Both All Parties acknowledge the obligation to comply with the Protocol and / or and/or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both All Parties agree to fulfil and ensure that their personnel and Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both The Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both The Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both Parties acknowledge the obligation to comply with the Protocol and / or and/or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both All Parties acknowledge the obligation to comply with the Protocol and / or and/or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both All Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

Adverse Event Reporting. Both All Parties acknowledge the obligation to comply with the Protocol and / or Clinical Investigation Plan and/or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical TrialInvestigation. Both All Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.